HK market uptrend intact; internet, insurance, brokerage outperform |
HSI retreated from overbought level, support at Jun-high |
HSI broke out on strong volume; financials led gains |
HSI set 3-month high with US-China relations in focus |
【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – First 5-yr follow-up results for VenusA and updated results for first retrievable TAVR in China |
HK/China markets surged on strong volume, lifting brokerage/insurance/property |
HSI target range 23,800-26,200 in 2H |
HSI set to rebound but showed signs of turning weak |
HSI to test uptrends as risk aversion rises |
Gold can be safe haven as U.S. new COVID-19 cases rebound |